Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.
about
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@ast
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@en
type
label
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@ast
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@en
prefLabel
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@ast
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Limitations in predicting PAM5 ...... e HER2-negative breast cancer.
@en
P2093
Aleix Prat
Antonio González
Barbara Adamo
Eva Carrasco
Giuseppe Perrone
Giuseppe Tonini
Immaculada Alonso
Joan Albanell
Juan de la Haba
Judit Matito
P2860
P304
21930-21937
P356
10.18632/ONCOTARGET.15748
P407
P50
P577
2017-03-01T00:00:00Z